Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous stromal vascular fraction + platelet-rich plasma (King Edward Medical University)
- Development stage
- Unknown
- Lead developer
- King Edward Medical University
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Injection
01
Overview
This autologous combination therapy consists of adipose-derived stromal vascular fraction (SVF) and platelet-rich plasma (PRP). Developed by researchers at King Edward Medical University, it is an investigational biologic treatment for androgenetic alopecia. The PRP component provides a concentrated source of growth factors, including platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF), which stimulate hair follicle proliferation and angiogenesis. The SVF component contains a heterogeneous population of cells, including adipose-derived mesenchymal stem cells (ADSCs), which contribute to tissue regeneration and the modulation of the hair cycle. The therapy is administered via local injection into the scalp to reverse the effects of patterned hair loss.
- Other names
- Adipose Tissue Derived Stem Cell Based Hair Restoration TherapySVF-PRP combination therapy
Beyond the preview
Go deeper on autologous stromal vascular fraction + platelet-rich plasma (King Edward Medical University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous stromal vascular fraction + platelet-rich plasma (King Edward Medical University).